Biochemistry, Genetics and Molecular Biology
Allele
23%
Antigen Presentation
22%
Autosomal Dominant Polycystic Kidney
39%
Autosomal Recessive Inheritance
19%
Biogenesis
46%
Bone Morphogenetic Protein 2
26%
Bromodomain
19%
Calcium Cell Level
23%
Cancer Cell
62%
Candidate Gene
23%
CLCN2
19%
Clonal Evolution
19%
Drug Resistance
40%
Epidermal Growth Factor Receptor
100%
Exome
30%
Exome Sequencing
84%
Ezrin
23%
Gene Mutation
31%
Genetics
90%
Homeostasis
26%
Immune Checkpoints
89%
Internalization
29%
Jasmonate
19%
Kinase
22%
KRAS
26%
Lipid Raft
29%
Long Non-Coding RNA
19%
MAP2K4
29%
Mouse
42%
Mouse Model
37%
Mutational Load
28%
Overall Survival
22%
PAX7
19%
Pembrolizumab
39%
Pig
19%
Polymerase
19%
Proband
46%
Receptor Tyrosine Kinase
39%
Runs Of Homozygosity
26%
Scaffold Protein
22%
Signal Transduction
39%
Somatic Mutation
26%
Stem Cell
44%
T Cell
27%
Transcription Factors
29%
Transcriptome
19%
Transcriptomics
24%
Tumor Progression
31%
Tumor Suppressor Gene
25%
Tyrosine Kinase
39%
Medicine and Dentistry
Anchorage Independent Growth
19%
Antigen Presentation
23%
Autophagy
19%
B Cell
19%
Carcinosarcoma
19%
Cisplatin
19%
Cohort Analysis
22%
Colorectal Cancer
19%
Disease
29%
Drug Resistance
19%
Endometrial Cancer
19%
Endothelial Cell
19%
Epidermal Growth Factor Receptor
77%
Exome Sequencing
37%
G Protein Coupled Receptor
19%
Gene Amplification
19%
Gene Mutation
20%
Genetic Trait
24%
Gynecological Oncology
19%
Homeostasis
23%
Hyperactivation
19%
Immune Checkpoint Inhibitor
35%
Leiomyosarcoma
39%
Liver Polycystic Disease
59%
Lung Cancer
79%
Lymphopoiesis
31%
Lymphotoxin
19%
Lymphotoxin Beta Receptor
19%
Mesenchymal Stem Cell
19%
microRNA 10b
19%
Microsatellite Instability
19%
Myelopoiesis
19%
Neoplasm
94%
Nociceptor
19%
Olaparib
19%
Osimertinib
26%
Overall Survival
23%
Pembrolizumab
19%
Poly ADP Ribose Polymerase
19%
Polycystic Kidney Disease
66%
Polycystin 1
23%
Portal Hypertension
19%
Progression Free Survival
21%
Proteus Syndrome
19%
Receptor
19%
Signal Transduction
19%
T Cell
19%
Transcriptome
19%
Transcriptomics
23%
Tumor Suppressor Gene
19%
Keyphrases
Acid Activation
19%
Autophagy
19%
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
26%
Cisplatin Resistance
19%
CLCN2
19%
Clonal Evolution Analysis
19%
DNAH2
19%
Elimusertib
19%
Epididymal Maturation
19%
ERBB2 mutation
19%
ERCC8
19%
Exceptional Responders
19%
FAM120A
19%
Familial Hyperaldosteronism Type II
19%
Familial Pulmonary Fibrosis
19%
Genetic Rearrangement
19%
Genome Remodeling
19%
GIMAP5
19%
High-grade Neuroendocrine Carcinoma
19%
Homologous Recombination Deficiency
19%
Hypobetalipoproteinemia
19%
Induced Gene
19%
Intestinal Pseudo-obstruction
19%
Intracellular Infection
19%
Jasmonic Acid
19%
Landscape Analysis
19%
Lineage Plasticity
19%
Liver Cancer
19%
Lymphotoxin beta Receptor (LTβR)
19%
Lynch-like
19%
MAL2
19%
MAP2K4
22%
Multiple Morphological Abnormalities of the Sperm Flagella
19%
Myelokathexis
19%
MYH11
19%
Nociceptor
19%
ORA59
19%
Plasma Circulating Tumor DNA
19%
Poly(adenosine diphosphate-ribose) Polymerase inhibitor
19%
Polycystic Kidney Disease
19%
Polycystic Liver Disease
39%
Polycystin
19%
Poor Prognosis
19%
Prime Editing
19%
Prime Editor
19%
Pseudogene
19%
RTEL1
19%
Syndromic Craniosynostosis
19%
T Cell Lymphopenia
19%
Uterine Leiomyosarcoma
19%